Isocitrate dehydrogenase | Radiology Reference Article | Radiopaedia.org
Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas | PLOS ONE
IDH1 mutation diminishes aggressive phenotype in glioma stem cells
Molecular Markers of Gliomas to Predict Treatment and Prognosis: Current State and Future Directions | Exon Publications
Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma | Cell Death & Disease
Frontiers | Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer
Low pH Facilitates Heterodimerization of Mutant Isocitrate Dehydrogenase IDH1-R132H and Promotes Production of 2-Hydroxyglutarate | Biochemistry
Frontiers | Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response | Science Translational Medicine
Wild-type and mutated IDH1/2 enzymes and therapy responses | Oncogene
IDH1 mutation in primary GBM: impact on patients' overall survival and... | Download Scientific Diagram
Glioma Classification Markers ATRX, IDH1, and GFAP - Atlas Antibodies
Cancers | Free Full-Text | Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth
Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation - ScienceDirect
Single-nucleus transcriptomics of IDH1- and TP53-mutant glioma stem cells displays diversified commitment on invasive cancer progenitors | Scientific Reports
Current model of the impact of IDH1 mutation on chromatin remodeling.... | Download Scientific Diagram
IVD Antibody Development Services for IDH1 Marker - Creative Biolabs
IDH1‑R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR
The implications of IDH mutations for cancer development and therapy | Nature Reviews Clinical Oncology
IDH1 mutations induce organelle defects via dysregulated phospholipids | Nature Communications
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets | British Journal of Cancer
Model for classification of gliomas based on molecular markers. IDH1/2... | Download Scientific Diagram
Biomedicines | Free Full-Text | IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?
Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas | PLOS ONE
